UK Immunotherapy Biotech raises Massive Funding in Series C – Labiotech.eu (blog)
Bdaily |
UK Immunotherapy Biotech raises Massive Funding in Series C
Labiotech.eu (blog) The UK biotech Cell Medica picked up a massive €69M (£60M) in its recent Series C funding round to advance its cancer immunotherapy programs. Cell Medica is a clinical stage company developing cell-based therapies to treat cancer. With the aim of … Cell Medica Raises £60M for Phase II T-Cell Product and Cell Immunotherapy Pipeline Cell Medica: £60 Million Series C Financing to Advance Multiple Cancer Programmes Cell Medica's £60m Series C has potential to 'transform' cancer treatment |
